Next Article in Journal
A Review of Microwave-Assisted Reactions for Biodiesel Production
Next Article in Special Issue
Tumor Microenvironment on a Chip: The Progress and Future Perspective
Previous Article in Journal
Recent Advances and Challenges towards Sustainable Polyhydroxyalkanoate (PHA) Production
Previous Article in Special Issue
Microtechnology-Based Multi-Organ Models
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle
Bioengineering 2017, 4(2), 56;

Three-Dimensional Culture Model of Skeletal Muscle Tissue with Atrophy Induced by Dexamethasone

Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya 464-8603, Japan
Innovative Research Center for Preventive Medical Engineering, Nagoya University, Nagoya 464-8601, Japan
Author to whom correspondence should be addressed.
Academic Editor: Hyun Jung Kim
Received: 12 April 2017 / Revised: 12 June 2017 / Accepted: 12 June 2017 / Published: 15 June 2017
(This article belongs to the Special Issue Human Organs-on-Chips for In Vitro Disease Models)
Full-Text   |   PDF [1857 KB, uploaded 15 June 2017]   |  


Drug screening systems for muscle atrophy based on the contractile force of cultured skeletal muscle tissues are required for the development of preventive or therapeutic drugs for atrophy. This study aims to develop a muscle atrophy model by inducing atrophy in normal muscle tissues constructed on microdevices capable of measuring the contractile force and to verify if this model is suitable for drug screening using the contractile force as an index. Tissue engineered skeletal muscles containing striated myotubes were prepared on the microdevices for the study. The addition of 100 µM dexamethasone (Dex), which is used as a muscle atrophy inducer, for 24 h reduced the contractile force significantly. An increase in the expression of Atrogin-1 and MuRF-1 in the tissues treated with Dex was established. A decrease in the number of striated myotubes was also observed in the tissues treated with Dex. Treatment with 8 ng/mL Insulin-like Growth Factor (IGF-I) for 24 h significantly increased the contractile force of the Dex-induced atrophic tissues. The same treatment, though, had no impact on the force of the normal tissues. Thus, it is envisaged that the atrophic skeletal muscle tissues induced by Dex can be used for drug screening against atrophy. View Full-Text
Keywords: cell-based assay; disease model; drug screening; contractile force; microdevice cell-based assay; disease model; drug screening; contractile force; microdevice

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Shimizu, K.; Genma, R.; Gotou, Y.; Nagasaka, S.; Honda, H. Three-Dimensional Culture Model of Skeletal Muscle Tissue with Atrophy Induced by Dexamethasone. Bioengineering 2017, 4, 56.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Bioengineering EISSN 2306-5354 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top